title: Neonatal group B streptococcus sepsis after negative screen in a patient taking oral antibiotics.
abstract: BACKGROUND
  Group B streptococcus (GBS) is a leading cause of serious neonatal infection. Neonatal morbidity and mortality can be reduced by appropriate prenatal screening and intrapartum chemoprophylaxis.
  
  
  METHODS
  A 20-year-old primigravida was treated with oral antibiotics at 35 weeks for a recurrent urinary tract infection. Her GBS screen following the antibiotic treatment showed a negative culture. The patient, therefore, did not receive intravenous antibiotics during her induction of labor for mild preeclampsia. The infant developed early onset neonatal GBS pneumonia and sepsis.
  
  
  CONCLUSIONS
  Oral antibiotics can cause a temporary negative culture in a GBS-colonized patient. Relying on a negative culture for management may not be appropriate in a patient treated with oral antibiotics. Additional studies are necessary to elucidate the effects of oral antibiotics on GBS.
authors.affiliation: Department of Obstetrics and Gynecology, Wright-Patterson Medical Center, Dayton, Ohio 45433, USA. david.kim@wpafb.af.mil
authors.forename: David D
authors.initials: DD
authors.lastname: Kim
authors.forename: Sarah M
authors.initials: SM
authors.lastname: Page
authors.forename: David S
authors.initials: DS
authors.lastname: McKenna
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Kim
mesh_terms: D000284:Administration, Oral; D000328:Adult; D017963:Azithromycin / Q000008:administration & dosage*; D016470:Bacteremia / Q000175:diagnosis / Q000628:therapy / Q000635:transmission*; D003131:Combined Modality Therapy; D005188:False Negative Reactions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis* / Q000628:therapy; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000382:microbiology; D011256:Pregnancy Outcome; D018570:Risk Assessment; D013290:Streptococcal Infections / Q000175:diagnosis / Q000628:therapy / Q000635:transmission*; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000302:isolation & purification*; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D017963:Azithromycin